Articles

Information technology stocks have shaken off their summertime blues, even reclaiming the top spot on the stock market’s 2024 leaderboard.

Fannie Mae CEO Priscilla Almodovar talks to MarketWatch about how the lock-in effect, high mortgage rates and climate risk are affecting home buyers.

Nvidia’s stock packs the ability to take big swings regularly, even as the company’s market cap has swelled enough to garner large weightings in indexes.

“What is the best plan for the three accounts that are just sitting there?”

The stock of small-cap biotech Jaguar Health Inc. rose 7% on Wednesday, after the company launched its gelclair treatment for oral mucositis, a common side effect suffered by head and neck cancer patients.

The Hennessy Core Growth Fund follows a highly rated strategy of selecting its entire portfolio from scratch once a year.

A day after a profit warning that rocked the stock market, executives at ASML Holding said the slower-than-expected recovery in the microchip market will have the sharpest impact on sales to China while having a relatively minor impact on sales of its most advanced systems elsewhere in the world. 

Tech companies are embracing the construction of new small modular reactors, which could have nuanced implications for nuclear stocks that have been some of the biggest gainers of 2024.

They’re not good for workers and distract from the key issue: continuous coverage

Cambria Investment’s Faber tells MarketWatch how he makes shareholders money by owning high-quality, dividend-paying stocks that most investors overlook.

Abbott Laboratories on Wednesday reported better-than-expected third-quarter earnings and sales, boosted by strength in the company’s medical-devices business.

Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its COVID-19-and-flu combination and stand-alone flu vaccine candidates, following a case of motor neuropathy in a participant in a mid-stage trial.